Codex Capital Asset Management’s Eli Lilly LLY Stock Holding History

Codex Capital Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.9M	Hold	18,380	–	–	6.54%	3
2025 Q4	$19.8M	Buy	18,380 +1,380	+8%	+$1.32M	7.18%	2
2025 Q3	$13M	Hold	17,000	–	–	4.88%	6
2025 Q2	$13.3M	Hold	17,000	–	–	5.3%	5
2025 Q1	$14M	Hold	17,000	–	–	6.62%	4
2024 Q4	$13.1M	Hold	17,000	–	–	5.81%	4
2024 Q3	$15.1M	Sell	17,000 -1,000	-6%	-$899K	6.68%	4
2024 Q2	$15.4M	Buy	+18,000	New	+$14.4M	7.05%	3

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Codex Capital Asset Management's LLY Position: Q1 2026 in Review

Codex Capital Asset Management held its Eli Lilly (LLY) position steady in Q1 2026 at 18,380 shares worth $16.9M. The position accounts for 6.54% of the portfolio, ranked #3.

Codex Capital Asset Management first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $19.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Codex Capital Asset Management held 18,380 shares of Eli Lilly worth $16.9M as of Q1 2026.
Codex Capital Asset Management left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 6.54% of Codex Capital Asset Management's portfolio in Q1 2026, its #3 holding.
Codex Capital Asset Management first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
Codex Capital Asset Management's Eli Lilly position peaked at $19.8M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Codex Capital Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.